These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6761510)

  • 21. [The value of the Emit-dau system in the examination of cadaveric urine].
    Szathmary S; Daldrup T
    Z Rechtsmed; 1984; 92(2):101-7. PubMed ID: 6372310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluation.
    Tóth M; Bereczki A; Drabant S; Nemes KB; Varga B; Grézal G; Tömlo J; Lakner G; Klebovich I
    J Pharm Biomed Anal; 2006 Jun; 41(4):1354-9. PubMed ID: 16682162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A radioreceptor assay for diazepam and its metabolites in serum.
    Owen F; Lofthouse R; Bourne RC
    Clin Chim Acta; 1979 May; 93(3):305-10. PubMed ID: 445851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct and indirect homogeneous enzyme immunoassay of benzodiazepines in biological fluids and tissues.
    Slightom EL; Cagle JC; McCurdy HH; Castagna F
    J Anal Toxicol; 1982; 6(1):22-5. PubMed ID: 7043088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity testing of commercial urine cocaine metabolite assays: IV. Evaluation of the EMIT d.a.u. cocaine metabolite assay in a quantitative mode for detection of cocaine metabolite.
    Cone EJ; Yousefnejad D; Dickerson SL
    J Forensic Sci; 1990 Jul; 35(4):786-91. PubMed ID: 2202774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.
    Pettersson Bergstrand M; Meyer MR; Beck O; Helander A
    Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of the EMIT tox benzodiazepine assay for screening of alprazolam in serum.
    Fraser AD; Bryan W; Isner AF
    J Anal Toxicol; 1988; 12(4):197-9. PubMed ID: 3054318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of plasma phenytoin level determinations by EMIT and gas-liquid chromatography in patients with renal insufficiency.
    Nandedkar AK; Williamson R; Kutt H; Fairclough GF
    Ther Drug Monit; 1980; 2(4):427-30. PubMed ID: 7013169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of lidocaine free concentration.
    Beach CL; Ludden TM; Clementi WA; Allerheiligen SR
    Ther Drug Monit; 1986; 8(3):326-30. PubMed ID: 3529515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary screening for midazolam and its major metabolites with the Abbott ADx and TDx analyzers and the EMIT d.a.u. benzodiazepine assay with confirmation by GC/MS.
    Fraser AD; Bryan W; Isner AF
    J Anal Toxicol; 1991; 15(1):8-12. PubMed ID: 2046344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of enzyme immunoassay and gas chromatography/mass spectrometry in forensic toxicology.
    Fenton J; Schaffer M; Chen NW; Bermes EW
    J Forensic Sci; 1980 Apr; 25(2):314-9. PubMed ID: 6993619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micro-extraction of commonly abused benzodiazepines for urinary screening by liquid chromatography.
    Wolff K; Garretty D; Hay AW
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():61-7. PubMed ID: 9022889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. False-positive EMIT indication of opiates and methadone in a doxylamine intoxication.
    Hausmann E; Kohl B; von Boehmer H; Wellhöner HH
    J Clin Chem Clin Biochem; 1983 Oct; 21(10):599-600. PubMed ID: 6358402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of benzodiazepine derivative mixture by gas-liquid chromatography].
    Zevzikovas A; Kiliuviene G; Ivanauskas L; Dirse V
    Medicina (Kaunas); 2002; 38(3):316-20. PubMed ID: 12474705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid detection and quantification of 35 benzodiazepines in urine by GC-TOF-MS.
    Arnhard K; Schmid R; Kobold U; Thiele R
    Anal Bioanal Chem; 2012 May; 403(3):755-68. PubMed ID: 22447215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EMIT-st drug detection system for screening of barbiturates and benzodiazepines in serum.
    Drost RH; Plomp TA; Maes RA
    J Toxicol Clin Toxicol; 1982 May; 19(3):303-12. PubMed ID: 6752436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of GLC-EMIT analysis for the assay of methadone and its major metabolite in urine.
    Ferrara SD; Tedeschi L; Castagna F; Marigo M
    Forensic Sci; 1978; 11(3):181-8. PubMed ID: 680610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The screening and quantitation of diazepam, flurazepam, chloridazepoxide, and their metabolites in blood and plasma by electron-capture gas chromatography and high pressure liquid chromatography.
    Peat MA; Kopjak L
    J Forensic Sci; 1979 Jan; 24(1):46-54. PubMed ID: 512615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of the EMIT drug abuse urine assay methods.
    Allen LV; Stiles ML
    Clin Toxicol; 1981 Sep; 18(9):1043-65. PubMed ID: 7032834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.